PRMT1 and cancer: Dysregulation of PRMT1 expression has been consistently identified in diverse human malignancies, including breast, lung, colon, and bladder cancers, as well as leukemia [9], with extensive research elucidating its regulatory role and substantial prognostic significance in these cancers [17,18].